These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 10094974)

  • 1. Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon-sensitive virus replication.
    Polyak SJ; Paschal DM; McArdle S; Gale MJ; Moradpour D; Gretch DR
    Hepatology; 1999 Apr; 29(4):1262-71. PubMed ID: 10094974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis.
    François C; Duverlie G; Rebouillat D; Khorsi H; Castelain S; Blum HE; Gatignol A; Wychowski C; Moradpour D; Meurs EF
    J Virol; 2000 Jun; 74(12):5587-96. PubMed ID: 10823866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation.
    Gale M; Blakely CM; Kwieciszewski B; Tan SL; Dossett M; Tang NM; Korth MJ; Polyak SJ; Gretch DR; Katze MG
    Mol Cell Biol; 1998 Sep; 18(9):5208-18. PubMed ID: 9710605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of mutation in hepatitis C virus nonstructural protein 5A on interferon resistance mediated by inhibition of PKR kinase activity in mammalian cells.
    Noguchi T; Satoh S; Noshi T; Hatada E; Fukuda R; Kawai A; Ikeda S; Hijikata M; Shimotohno K
    Microbiol Immunol; 2001; 45(12):829-40. PubMed ID: 11838900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy.
    Nousbaum J; Polyak SJ; Ray SC; Sullivan DG; Larson AM; Carithers RL; Gretch DR
    J Virol; 2000 Oct; 74(19):9028-38. PubMed ID: 10982347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NS5A protein of hepatitis C virus partially inhibits the antiviral activity of interferon.
    Song J; Fujii M; Wang F; Itoh M; Hotta H
    J Gen Virol; 1999 Apr; 80 ( Pt 4)():879-886. PubMed ID: 10211956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nonstructural 5A protein of hepatitis C virus genotype 1b does not contain an interferon sensitivity-determining region.
    Brillet R; Penin F; Hezode C; Chouteau P; Dhumeaux D; Pawlotsky JM
    J Infect Dis; 2007 Feb; 195(3):432-41. PubMed ID: 17205483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the interferon-sensitivity determining region of hepatitis C virus and transcriptional activity of the nonstructural region 5A protein.
    Fukuma T; Enomoto N; Marumo F; Sato C
    Hepatology; 1998 Oct; 28(4):1147-53. PubMed ID: 9755255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response.
    Polyak SJ; Khabar KS; Paschal DM; Ezelle HJ; Duverlie G; Barber GN; Levy DE; Mukaida N; Gretch DR
    J Virol; 2001 Jul; 75(13):6095-106. PubMed ID: 11390611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus: the role of molecular mimicry in response to interferon treatment.
    Uzicanin S; Hu YW; Alsousi H; Pelchat M; Rocheleau L; Nair RC; Brown EG
    J Med Virol; 2012 Oct; 84(10):1571-85. PubMed ID: 22930505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of interferon-induced antiviral activity in cells expressing hepatitis C virus proteins.
    Aizaki H; Saito S; Ogino T; Miyajima N; Harada T; Matsuura Y; Miyamura T; Kohase M
    J Interferon Cytokine Res; 2000 Dec; 20(12):1111-20. PubMed ID: 11152578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase.
    Gale M; Kwieciszewski B; Dossett M; Nakao H; Katze MG
    J Virol; 1999 Aug; 73(8):6506-16. PubMed ID: 10400746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long-lasting response to interferon therapy in patients with HCV-1b chronic hepatitis?
    Squadrito G; Raffa G; Restuccia T; Pollicino T; Brancatelli S; Raimondo G
    J Viral Hepat; 2002 Sep; 9(5):360-9. PubMed ID: 12225331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b.
    Hofgärtner WT; Polyak SJ; Sullivan DG; Carithers RL; Gretch DR
    J Med Virol; 1997 Oct; 53(2):118-26. PubMed ID: 9334922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repression of the PKR protein kinase by the hepatitis C virus NS5A protein: a potential mechanism of interferon resistance.
    Gale MJ; Korth MJ; Katze MG
    Clin Diagn Virol; 1998 Jul; 10(2-3):157-62. PubMed ID: 9741641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The non-structural 5A protein of hepatitis C virus exhibits genotypic differences in interferon antagonism.
    Tsai YH; Kuang WF; Lu TY; Kao JH; Lai MY; Liu CJ; Chen PJ; Hwang LH
    J Hepatol; 2008 Dec; 49(6):899-907. PubMed ID: 18842320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein.
    Gale MJ; Korth MJ; Tang NM; Tan SL; Hopkins DA; Dever TE; Polyak SJ; Gretch DR; Katze MG
    Virology; 1997 Apr; 230(2):217-27. PubMed ID: 9143277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of mRNA translation and cellular signaling by hepatitis C virus nonstructural protein NS5A.
    He Y; Tan SL; Tareen SU; Vijaysri S; Langland JO; Jacobs BL; Katze MG
    J Virol; 2001 Jun; 75(11):5090-8. PubMed ID: 11333890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus NS5A protein interacts with 2',5'-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining region-independent manner.
    Taguchi T; Nagano-Fujii M; Akutsu M; Kadoya H; Ohgimoto S; Ishido S; Hotta H
    J Gen Virol; 2004 Apr; 85(Pt 4):959-969. PubMed ID: 15039538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity.
    Duverlie G; Khorsi H; Castelain S; Jaillon O; Izopet J; Lunel F; Eb F; Penin F; Wychowski C
    J Gen Virol; 1998 Jun; 79 ( Pt 6)():1373-81. PubMed ID: 9634077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.